HealthStream (HSTM) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 was $73.5 million, up 1% year-over-year; net income was $4.3 million, down 17.1%; operating income declined 23.1% to $4.4 million; adjusted EBITDA was $16.2 million, down 5% year-over-year.

• The company is a market leader in workforce solutions for U.S. healthcare, serving a large, regulated industry and expanding its addressable market to nursing schools and students.

• Closed the largest deal in its history, a $14 million, five-year contract with a major health system, while several medium-sized deals were delayed into Q2.

• Subleased office space in Nashville, expected to reduce lease expense by $2.3 million in 2025 and $3.2 million annually thereafter.

• Board transition: Dr. William Stead retiring after 27 years; Charles Beard Jr. joined the board in March 2025.

Financial highlights

• Revenues: $73.5 million (+1% YoY); Operating income: $4.4 million (-23.1% YoY); Net income: $4.3 million (-17.1% YoY); EPS: $0.14 (down from $0.17 YoY).

• Adjusted EBITDA: $16.2 million (-5% YoY); Adjusted EBITDA margin: 22% (down from 23.4%).

• Gross margin: 65.3% (down from 66.2% YoY); operating margin: 6.0%.

• Free cash flow: $18.2 million (+38.3% YoY); cash, cash equivalents, and marketable securities totaled $113.3 million.

• Days sales outstanding improved to 37 days from 46 days YoY; working capital increased to $43.9 million.

Outlook and guidance

• Full-year 2025 revenue guidance revised to $297.5–$303.5 million; net income $18.6–$21 million; adjusted EBITDA $68.5–$72.5 million; capital expenditures expected at $31–$34 million.

• Revenue growth expected to be second-half weighted, with improvement anticipated as delayed deals close.

• Medium-term objectives: 5–7% organic revenue growth, 65–68% gross margin, and 21–24% adjusted EBITDA margin.

• Guidance reflects macroeconomic pressures and technology scaling issues, but bookings and sales pipelines remain strong.